Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

LENSAR Inc

LNSR
Current price
14.24 USD -0.01 USD (-0.07%)
Last closed 14.82 USD
ISIN US52634L1089
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 87 691 712 USD
Yield for 12 month +310.37 %
1Y
3Y
5Y
10Y
15Y
LNSR
21.11.2021 - 28.11.2021

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. Address: 2800 Discovery Drive, Orlando, FL, United States, 32826

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.00 USD

P/E ratio

Dividend Yield

Current Year

+42 164 000 USD

Last Year

+35 358 000 USD

Current Quarter

+13 539 000 USD

Last Quarter

+12 636 000 USD

Current Year

+21 107 000 USD

Last Year

+19 955 000 USD

Current Quarter

+6 266 000 USD

Last Quarter

+6 581 000 USD

Key Figures LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 357 000 USD
Operating Margin TTM -9.20 %
Price to Earnings
Return On Assets TTM -9.38 %
PEG Ratio
Return On Equity TTM -38.38 %
Wall Street Target Price 11.00 USD
Revenue TTM 48 868 000 USD
Book Value 1.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 38.20 %
Dividend Yield
Gross Profit TTM 19 955 000 USD
Earnings per share -1.42 USD
Diluted Eps TTM -1.42 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -34.03 %

Dividend Analytics LNSR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation LNSR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.41
Price Sales TTM 1.79
Enterprise Value EBITDA -1.04
Price Book MRQ 3.75

Financials LNSR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LNSR

For 52 weeks

2.45 USD 8.17 USD
50 Day MA 6.43 USD
Shares Short Prior Month 43 676
200 Day MA 4.76 USD
Short Ratio 1.20
Shares Short 58 384
Short Percent 0.61 %
Dividend information is being updated